Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

in vitro gene mutation study in mammalian cells
Type of genotoxicity: gene mutation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
1st April to 21st May 1985
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study following GLP. The reliability is reduced as the study is being used for read-across purposes.

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
equivalent or similar to guideline
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
not specified
GLP compliance:
Type of assay:
mammalian cell gene mutation assay

Test material

Constituent 1
Reference substance name:
Phenol, dodecyl-, sulfurized, carbonates, calcium salts, overbased.
Phenol, dodecyl-, sulfurized, carbonates, calcium salts, overbased.
Constituent 2
Reference substance name:
Cas Number:
Details on test material:
122384-87-6/68784-26-9/122384-86-5/68784-25-8. Phenol, dodecyl-, sulfurized, carbonates, calcium salts, overbased.
Testing was performed on a commercial sample of this material. Typical purity of this material as distributed in commerce is 50% alkyl phenol sulfide and 50% highly refined lubricant base oil.


Species / strain
Species / strain / cell type:
mouse lymphoma L5178Y cells
Details on mammalian cell type (if applicable):
Strain: 3.7.2C
Cells were cultured in Fischer's medium in a shaker incubator at 37°C in humidified 5% CO2 in air. Cultures were diluted daily to a cell density of approximately 3 x 10ˆ5 cells per ml. Each time a culture was used, it was checked for bacterial or fungal contamination.
Prior to use in the assay, L5178Y cells were treated with methotrexate to reduce the frequency of spontaneously occurring TK-/- cells.
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
Aroclor S-9 metabolic activation
Test concentrations with justification for top dose:
0, 75, 100, 150, 200, 250, and 275 µg/mL with S-9
0, 60, 70, 80, 90, 100, and 110 µg/mL without S-9
Vehicle / solvent:
5% Pluronic F-68 (surfactant, CAS # 9003-11-6) in water.
Untreated negative controls:
Negative solvent / vehicle controls:
True negative controls:
not specified
Positive controls:
Positive control substance:
Details on test system and experimental conditions:
Three replicate plates were evaluated for each treatment.

- Test Material Exposure: Based on the data derived from the toxicity test, the test material was prepared so that the highest concentration would yield a percent total growth of approximately 10%. The test material was solubilized and diluted to produce evenly spaced dose levels which would yield approximately 90% total growth at the lowest dose. The test material was added to cells, both with and without metabolic activation and incubated for approximately 4 hours. Cells were then washed and placed into suspension culture at a density of 0.3 x 10ˆ6 cells/mL.

- Expression Time: In order for induced mutations to be expressed, the cells must undergo several divisions. This period is designated as the expression time. After the initial exposure to the test material the cells were incubated for 2 days and adjusted to 0.3 x 10ˆ6 cells/mL at 24 hours.

- Cloning: At the end of the expression period, a portion of the cells were plated in
(a) restrictive medium containing trifluorothymidine (TFT) which allowed only the TK-/- cells to grow, and
(b) non-restrictive medium which indicated cell viability.
The plates were incubated at 37°C in humidified 5% CO2 in air for 10-12 days.

- Accumulation of Data: After the incubation period, both the mutagenicity (TFT restrictive medium) plates and the viability (non-restrictive medium) plates were scored for the total number of colonies per plate using an Artek 880 colony counter or by hand. The frequency of mutants induced by each test material dose was determined by comparing the average number of colonies in the mutagenicity plates to the average number of colonies in the corresponding viability plates. Induced mutagenic activity, if any, was quantified by comparing the mutant frequency of the treated plates to that of the control plates.

The test material was checked for toxicity with and without S-9 metabolic activation at dose levels of 10 ug/ml to 5000 µg/ml. Toxicity was observed at 100, 500, 1000, 2500 and 5000 ug/ml with and without S-9.

Evaluation criteria:
Criteria for an Acceptable Mouse Lymphoma Screen: All the following criteria should be met for the mutagenicity screen to be considered valid:
- The mutant frequency of the appropriate positive control (either with or without S-9 activation) should be at least twice that of the appropriate negative (solvent) control.
- The spontaneous mutant frequency of the negative (solvents control should be in the range of 0.2 to 2.0 per 10ˆ4 cells.
- The plating efficiency of the negative (solvent) control should be at or above 50%.
- The test material should be tested to the level of approximately 10% total growth, or the limits of solubility, or to a high dose of 10 mg/ml. Test materials may be tested as slurries.

Results and discussion

Test results
Species / strain:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Cytotoxicity / choice of top concentrations:
>100 µg/mL
Vehicle controls validity:
Untreated negative controls validity:
Positive controls validity:
Additional information on results:
Results of the preliminary Toxicity Test (not shown) conducted on the test material indicated significant toxicity at 100 µg/ml for the cultures with and without S-9 metabolic activation. Based on the results of the Toxicity Test, the test material was tested in the Mutagenicity Screen at concentrations ranging from 10 µg/ml to 275 µg/ml with metabolic activation and from 30 µg/ml to 110 µg/ml without activation. After the two-day expression period, six cultures with metabolic activation and six cultures without activation were selected for cloning based on the degree of observed toxicity. The cultures were cloned at 75, 100, 150, 200, 250, and 275 µg/ml (with metabolic activation) and 60, 70, 80, 90, 100, and 110 µg/ml (without activation).

None of the cultures treated with test material with or without metabolic activation exhibited mutant frequencies significantly different from the average mutant frequencies of the corresponding negative, solvent controls. Percent total growth ranged from 32% to 94% (with metabolic activation) and 10% to 95% (without activation). The positive control (DMBA) responded satisfactorily.

Under the conditions tested the test material was not mutagenic to L5178Y TK+/- cells in this assay.

Remarks on result:
other: all strains/cell types tested
Migrated from field 'Test system'.

Any other information on results incl. tables

First criterion for a valid test (as stated in the report) was not met without S-9, total growth only 32%. Total cell growth at the high dose without S-9 was 10%. Other test validity criteria were satisfied. The highest mutation frequency over control among all test doses was 4% with S-9 and 51% without S-9. There was no indication of a dose-related increase of mutation frequency with S-9. There was a trend without S-9 to higher mutation rates with progressively lower total growth at doses of 80-110 µg/mL. No statistical analysis was performed on the study results, as they were not needed.

Applicant's summary and conclusion

Interpretation of results (migrated information):

Under the conditions tested the test material was not mutagenic to L5178Y TK+/- cells in this assay.
Executive summary:

In a study conducted in line with OECD guideline 476 and under conditions of GLP the test material was tested in the L5178Y TK+/- Mutagenicity Screen with and without S-9 metabolic activation. The cultures with activation were tested at concentrations ranging from 75 µg/ml to 275 µg/ml; cultures without activation were tested at concentrations ranging from 60 µg/ml to 110 µg/ml.

The results indicated that the test material did not induce a significant increase in the mutant frequencies of cultures tested either with or without metabolic activation. Under the conditions tested the test material was not mutagenic in this screen.

The study is being used as read across to a structurally similar substance.